Clinical Trial Update: Recombinant Human Interleukin-7 (JL18008) for the Treatment of HIV-Infected Immunological Non-Responders [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating recombinant human interleukin-7 (JL18008) for HIV-infected immunological non-responders; the study is currently NOT_YET_RECR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Interleukin-7 (JL18008) (interleukin-7)

Snippet

Sponsor: Jecho Biopharmaceuticals Co., Ltd. | Conditions: HIV | Phase 1 | Status: NOT_YET_RECRUITING